Vaccines To Combat Drug Addiction are Inching Closer to Reality

Vaccine

Drug addiction is a massive issue that impacts not only on those with the addiction but also on their families. Furthermore, it is putting a strain on the healthcare system. In fact, it is estimated that in the United States, there is an average of drug addiction related deaths each and every day. By 2016, the number of deaths caused by either opioid painkillers or heroin had risen by five times since 1999. The Centers for Disease Control and Prevention (CDC) is working tirelessly to find a way of combating the epidemic of opioid drug abuse.

Using the data they have collected, the CDC has already determined that one of the biggest contributing factors to the significant rise in addictions and deaths is the overprescribing of medications by doctors. Although prescribing opioid painkillers is completely legal, it is a practice that is becoming increasingly common and has led to many people developing a dependence on the drugs.

One problem with this is the measures people will then go to when they need to obtain the drugs on which they are dependent but cannot get them from the doctors. They will then often turn to street drugs to overcome the symptoms of withdrawal they are experiencing. This puts them at greater risk of poisoning from unknown drugs or taking an accidental overdose.

While some conditions are easy to treat, this is not the case for addictions as these are notoriously difficult to conquer. For this reason, researchers have been investigating new ways to potentially beat addictions. One possible solution they are looking at is whether a vaccine has the potential to successfully help those with addictions.

This concept is something that scientists have been looking into since the 1970s. The Stripps Research Institute has recently published the findings of their work on developing a vaccine for the treatment of heroin addictions.

This vaccine works in the same way as any other immunization. The vaccine would make the body create antibodies. These would then bind to the heroin and the effect of this is that the heroin cannot pass through the blood-brain barrier. As a result, the user will not feel the high they usually experience after taking a dose of heroin. The theory is that if people are not experiencing the effects of heroin that they find enjoyable, then the likelihood of a relapse is significantly reduced.

It is not only those who are addicted to heroin that may benefit from such vaccines as there are also researchers working on similar vaccines for addictions to cocaine, nicotine, alcohol, opioid painkillers, and fentanyl. The need to research vaccines for each of these addictions is severe due to the sheer number of people who are affected by these issues.

So far, the benefits of these vaccines have been proven using animals in the laboratory. However, scientists now face the biggest challenge of all as they need to investigate whether the vaccines have the same positive implications for treating humans with addictions. Although the trials using animals have produced fantastic results, the same cannot be said for the initial trials with humans. In fact, the results of the earliest trials have been very disappointing. Things are not all bad as it is now over a decade since those initial trials were conducted. The positives that the researchers can draw on them is that it gave the scientists some valuable insights into what went wrong and how they can improve in the future. Overall, it was a good learning experience and they still feel they made progress.

Kelly E. Dunn, an Associate Professor of Psychiatry and Behaviour Science, works at John Hopkins University School of Medicine. She recently spoke about the latest findings to ‘Chemical and Engineering News’. She said of the vaccines that they are a novel and promising way of preventing substance abuse that provides a different mechanism than current methods. However, she also said that there is still a lot of work before these vaccines are used to treat humans with addictions.This view was supported by R. Corey Waller who has said that the need for intervention was so desperate that they are willing to continue looking into all the options. Waller is a practicing addiction specialist and serves the American Society of Addiction Medicine as the chair of the legislative advocacy committee.

Add Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Peter Colis
10 Things You Didn’t Know About Peter Colis
Business expenses
20 Things You Didn’t Know About Soldo
Arvind Purushotham
10 Things You Didn’t Know About Arvind Purushotham
Go1
20 Things You Didn’t Know About Go1
credit card
10 Things We Like about the Bilt Rewards Card
Credit Card
10 Reasons We Like The Divvy Business Credit Card
Tesla
The Top Five Stock Picks Targeted at Climate Change
Credit Card
The 20 Best Travel Credit Cards of 2021
The Rock and Roll Hall of Fame
The 20 Best Day Trips in Ohio
Red Cedar State Trail
The Best 20 Bike Trails in Wisconsin
Airline Miles
How You Can Now Redeem Miles for Flights to Space
Oklahoma State park
The 10 Best State Parks in Oklahoma
Mercedes-Benz is Spending $47 Billion on Its Electric Car Effort
10 Things You Didn’t Know about The Bugatti Divo
Dodge Raider
Remembering The Short Lived Dodge Raider
Aston Martin Cygnet
The History and Evolution of the Aston Martin Cygnet
Patek Phillipe’s Green-Dial Nautilus
A Closer Look at the Patek Philippe’s Green-Dial Nautilus
A Closer Look at the Creux Automatiq Ghost V3 Mono
Seven Fridays
A Closer Look at the SevenFriday’s P1C/04 Caipi Watch
Doxa Sub 200 Whitepearl
A Closer Look at the The Doxa Sub 200 Whitepearl
Nancy Cartwright
How Nancy Cartwright Achieved a Net Worth of $80 Million
Heart Evangelista
How Heart Evangelista Achieved a Net Worth of $3 Million
How Cote De Pablo Achieved a Net Worth of $6 Million
How Upchurch Achieved a Net Worth of $4 Million